• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • F. Mauvais-Jarvis, E. Sobngwi, +7 authors J. Gautier
  • Medicine
  • Diabetes
  • 2004 (First Publication: 1 March 2004)
  • Nonautoimmune ketosis-prone diabetic syndromes are increasingly frequent in nonwhite populations. We have characterized a cohort of patients of sub-Saharan African origin who had ketosis-prone type 2Expand
  • Athena Philis-Tsimikas, Guillaume Charpentier, Per Clauson, G. M. Ravn, Victor Lawrence Roberts, Birger Thorsteinsson
  • Medicine
  • Clinical therapeutics
  • 2006 (First Publication: 1 October 2006)
  • BACKGROUND Many patients with poorly controlled type 2 diabetes mellitus (DM) receive, as initial insulin treatment, the addition of a basal formulation to an existing regimen of oral antidiabeticExpand
  • A. Scheen, G. Charpentier, C. Ostgren, Å. Hellqvist, I. Gause-Nilsson
  • Medicine
  • Diabetes/metabolism research and reviews
  • 2010 (First Publication: 1 October 2010)
  • BACKGROUND Dipeptidyl peptidase-4 inhibitors improve glycaemic control in patients with type 2 diabetes mellitus when used as monotherapy or in combination with other anti-diabetic drugs (metformin,Expand
  • Andrew J Ahmann, Matthew S. Capehorn, +6 authors Vanita R Aroda
  • Medicine
  • Diabetes Care
  • 2017 (First Publication: 15 December 2017)
  • OBJECTIVE To compare the efficacy and safety of once-weekly semaglutide 1.0 mg s.c. with exenatide extended release (ER) 2.0 mg s.c. in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS InExpand
  • B. Neve, M. Fernández-Zapico, +24 authors P. Froguel
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences…
  • 2005 (First Publication: 29 March 2005)
  • KLF11 (TIEG2) is a pancreas-enriched transcription factor that has elicited significant attention because of its role as negative regulator of exocrine cell growth in vitro and in vivo. However, itsExpand